Characteristics of Trials Preceding FDA Approval of Novel Psychiatric Drugs
This cross-sectional study reports on the study design characteristics of clinical trials for novel psychiatric drugs approved by the US Food and Drug Administration.
Authors
- Erick H. Turner (ORCID: https://orcid.org/0000-0002-3522-3357)
- Aaron Seth Kesselheim (ORCID: https://orcid.org/0000-0002-8867-2666)
- Rosa Y. Ahn-Horst
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Oregon Health & Science University (US)
- McLean Hospital (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.56588
- Citations
- 2
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 2.79
Funders
- Massachusetts General Hospital
- Arnold Ventures
- National Institute of Mental Health